Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ovid Therapeutics Inc (NASDAQ: OVID).

Full DD Report for OVID

You must become a subscriber to view this report.


Recent News from (NASDAQ: OVID)

Ovid Therapeutics (OVID) Presents At Baird's Global Healthcare Conference - Slideshow
The following slide deck was published by Ovid Therapeutics Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 06 2018 15:13
Dr. Yaron Werber, Chief Business and Financial Officer, to Return to Wall Street
Dr. Werber will join Cowen and Company as Managing Director and Senior Biotechnology Analyst effective September 24, 2018 Ovid has initiated a search to select a new CFO NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company comm...
Source: GlobeNewswire
Date: September, 04 2018 16:05
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in September 2018
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that the company will present at two upcoming investor conferen...
Source: GlobeNewswire
Date: August, 29 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-146.186.086.386.0049,160

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-074,28116,34526.1915Cover
2018-12-0610,14531,11132.6090Cover
2018-12-044,74522,75520.8526Cover
2018-12-0315,90835,95844.2405Short
2018-11-301,2378,48914.5718Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OVID.


About Ovid Therapeutics Inc (NASDAQ: OVID)

Logo for Ovid Therapeutics Inc (NASDAQ: OVID)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: OVID)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: September, 04 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 06 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 06 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 19 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 16 2018
      Notice from the SEC of registration effectiveness
      Filing Type: EFFECTFiling Source: edgar
      Filing Date: June, 19 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: June, 11 2018
      Simplified registration form
      Filing Type: S-3Filing Source: edgar
      Filing Date: June, 01 2018

       

       


      Daily Technical Chart for (NASDAQ: OVID)

      Daily Technical Chart for (NASDAQ: OVID)


      Stay tuned for daily updates and more on (NASDAQ: OVID)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: OVID)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OVID is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OVID and does not buy, sell, or trade any shares of OVID. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/